Find Reports
Select Report Type
Reimbursement Review
Displaying 976 - 1000 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Histrelin acetate | Vantas | Histrelin acetate | Cancer, prostate | Do not list | Complete | SR0078-000 | |||
| Natalizumab | Tysabri | Natalizumab | Multiple Sclerosis, relapsing-remitting | Do not list | Complete | SR0082-000 | |||
| Deferasirox | Exjade | Deferasirox | Iron overload | List with clinical criteria and/or conditions | Complete | SR0081-000 | |||
| Sunitinib | Sutent | Sunitinib | Gastrointestinal stromal tumour (GIST) | List with clinical criteria and/or conditions | Complete | SR0069-000 | |||
| Rasagiline mesylate | Azilect | Rasagiline mesylate | Parkinson's disease | Do not list | Complete | SR0073-000 | |||
| Sorafenib tablets | Nexavar | Sorafenib tablets | Cancer, Renal cell carcinoma | Do not list | Complete | SR0071-000 | |||
| Rituximab | Rituxan | Rituximab | Arthritis, Rheumatoid | List with clinical criteria and/or conditions | Complete | SR0068-000 | |||
| Darunavir | Prezista | Darunavir | HIV infection | List with clinical criteria and/or conditions | Complete | SR0072-000 | |||
| Sildenafil citrate | Revatio | Sildenafil citrate | Pulmonary arterial hypertension (WHO class II and III) | List in a similar manner | Complete | SR0076-000 | |||
| Escitalopram oxalate | Cipralex | Escitalopram oxalate | Depression, Major Depressive Disorder (MDD) | Do not list | Complete | SR0064-000 | |||
| Solifenacin succinate | Vesicare | Solifenacin succinate | Bladder, overactive | Do not list | Complete | SR0070-000 | |||
| Ciclesonide | Alvesco | Ciclesonide | asthma | List | Complete | SR0074-000 | |||
| Adefovir dipivoxil | Hepsera | Adefovir dipivoxil | Hepatitis B | Do not list | Complete | SR0060-000 | |||
| Etonogestrel/ethinyl estradiol | NuvaRing | Etonogestrel/ethinyl estradiol | Contraceptive, ring | List with clinical criteria and/or conditions | Complete | SR0062-000 | |||
| Adalimumab | Humira | Adalimumab | Arthritis, Psoriatic | List with clinical criteria and/or conditions | Complete | SR0066-000 | |||
| Ramipril/felodipine extended r... | Altace Plus Felodipine | Ramipril/felodipine extended release | Hypertension | Do not list | Complete | SR0067-000 | |||
| Emtricitabine/tenofovir disopr... | Truvada | Emtricitabine/tenofovir disoproxil fumarate | HIV infection | List with clinical criteria and/or conditions | Complete | SR0063-000 | |||
| Insulin glargine (rDNA origin) | Lantus | Insulin glargine (rDNA origin) | Diabetes mellitus, Type 1 & 2 | Do not list | Complete | SR0058-000 | |||
| Voriconazole | VFEND | Voriconazole | Candidemia | List with clinical criteria and/or conditions | Complete | SR0056-000 | |||
| Darifenacin hydrobromide | Enablex | Darifenacin hydrobromide | Bladder, overactive | Do not list | Complete | SR0061-000 | |||
| Alefacept | Amevive | Alefacept | Psoriasis, moderate to severe chronic plaque | Do not list | Complete | SR0053-000 | |||
| Alendronate sodium/cholecalcif... | Fosavance | Alendronate sodium/cholecalciferol | Osteoporosis | Do not list | Complete | SR0059-000 | |||
| Efalizumab | Raptiva | Efalizumab | Psoriasis, moderate to severe chronic plaque | List with clinical criteria and/or conditions | Complete | SR0043-000 | |||
| Travoprost and timolol maleate | DuoTrav | Travoprost and timolol maleate | Glaucoma | List with clinical criteria and/or conditions | Complete | SR0057-000 | |||
| Trospium chloride | Trosec | Trospium chloride | Bladder, overactive | List with clinical criteria and/or conditions | Complete | SR0055-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 976 - 1000 of 2132
Please scroll or swipe to the right to view the full content.